Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bristol Myers Squibb Company BMY

Healthcare  —  Drug Manufacturers General
62.86 1.36 2.21% as of 25 Sep
Market cap
$125.9B
P/E
13.8×
S&P 500 Member Dividend Aristocrat
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bristol Myers Squibb Company (BMY) P/E ratio

As of 25 September 2026, Bristol Myers Squibb Company (BMY) trades at a P/E ratio of 13.8×. Over the past ten years it has ranged from 0.0× (March 2025) to 259× (September 2018); the current reading is higher than 28% of that period. That is below the Drug Manufacturers General industry median of 24.7× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 15.6× —
FY2024 0.0× —
FY2023 13.6× (43.92%)
FY2022 24.2× 22.51%
FY2021 19.8× —
FY2020 0.0× —
FY2019 29.0× 69.31%
FY2018 17.2× (82.93%)
FY2017 101× 351.40%
FY2016 22.3× (69.71%)

Quarterly

Period P/E ratio Change
Jun 2026 12.7× (25.50%)
Mar 2026 17.0× 9.28%
Dec 2025 15.6× 2.66%
Sep 2025 15.2× (18.32%)
42 more quarters

Against its own ten years

Low 0.0× High 259×
Ten-year median 18.9×
Current reading's percentile 28

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company 13.8×
GSK GSK PLC Sponsored ADR compare 15.3×
SNY Sanofi compare 21.5×
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. compare 25.6×
PFE Pfizer Inc. compare 37.7×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BMY